NBTY tabs former Coca-Cola exec as international president

Print Friendly, PDF & Email

RONKONKOMA, N.Y. — Kevin Warren has joined NBTY Inc. as president of NBTY International.


Kevin Warren

NBTY said Thursday that Warren, who comes to the vitamin and dietary supplement maker after a long career at Coca-Cola, will provide strategic leadership in recognizing and optimizing opportunities for further geographic penetration and profitable, sustainable growth in mature and emerging international markets.

In the role, Warren will be responsible for the creation of targeted growth strategies for brands such as Solgar, Nature’s Bounty and MET-Rx. He also will drive the development of new business partnerships and oversee the all vendor and affiliate relationships outside the Americas.

Plans call for Warren to start as NBTY International president on Sept. 28. He will be based in the United Kingdom.

“I am delighted to welcome Kevin to NBTY. As the company continues to grow, we recognize that the breadth and depth of our international business will play a pivotal role in helping to establish NBTY as the unequivocal global leader in wellness products,” stated Steve Cahillane, president and chief executive officer of NBTY. “Kevin is a driven and effective leader with extensive global experience in consumer goods. He is uniquely qualified to lead our International business and I am confident that he will take it to new heights.”

Warren retired from Coca-Cola earlier this year after 25 years with the company, where he held a variety of international leadership positions. Most recently, he served as region director for Russia, Middle East and Africa in Coca-Cola’s Bottling Investments Group. Before that, he was president and general manager of Coca-Cola Enterprises (CCE) Canada and held the position of president and general manager of CCE United Kingdom.

Prior to joining Coca-Cola, Warren worked for The Walt Disney Co. in the United States and at leisure and travel organizations in the United Kingdom.


Adheris Health

Comments are closed.

Adheris Health